Summary: The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biobetters are the next big opportunity for biopharma to benefit from this growth. This podcast will explore the regulatory and scientific considerations for the development of biobetters. Thought Leader: Hazel Gorham, Ph.D., Director, Biosimilars Development, PRA Play podcast
